SAREPTA THERAPEUTICS INC (SRPT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SRPT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SRPT | Non-Employee Director | 65 | ["Leadership Experience","Industry Knowledge","Sales or Marketing Experience","Accounting or Audit Experience","Public Company Board Experience"] | ["Compensation Committee","Nominating and Corporate Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Deirdre Connelly has served as a member of our Board since September 2024. She also serves as a member of and chair of our compensation committee and member of our nominating and corporate governance committee. She retired as president, North America Pharmaceuticals for GlaxoSmithKline (GSK) in 2015, a role she had held since 2009. Prior to joining GSK, she was with Eli Lilly and Company, where she served as president, U.S. Pharmaceutical Operations from 2005 to 2009. During her 26-year career with Eli Lilly, she held a variety of executive positions, including senior vice president of human resources for the corporation, as well as vice president of human resources for pharmaceutical operations. Ms. Connelly currently serves on the board of directors at Macy s Corporation and Lincoln Financial Group, in addition to serving as the Chairperson of the Board at Genmab A/B. Ms. Connelly holds a Bachelor s degree in Economics and Business Management from Lycoming College and is a graduate of Harvard University's Advanced Management Program. Our nominating and corporate governance committee believes that Ms. Connelly s extensive industry and significant leadership experiences qualify her for service as a member of our Board.